Progress in Free Energy Perturbation: Options for Evolving Fragments

Drug Discov Today Technol. 2021 Dec:40:36-42. doi: 10.1016/j.ddtec.2021.10.001. Epub 2021 Nov 18.

Abstract

One of the remaining bottlenecks in fragment-based drug design (FBDD) is the initial exploration and optimization of the identified hit fragments. There is a growing interest in computational approaches that can guide these efforts by predicting the binding affinity of newly designed analogues. Among others, alchemical free energy (AFE) calculations promise high accuracy at a computational cost that allows their application during lead optimization campaigns. In this review, we discuss how AFE could have a strong impact in fragment evolution, and we raise awareness on the challenges that could be encountered applying this methodology in FBDD studies.

Keywords: Computer-aided drug design; Fragment-based drug design; Free energy perturbation; Molecular dynamics; Relative binding free energy.

Publication types

  • Review